Bernardo, Elvie .

HRN: 08-62-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
CO-AMOXICLAV 625MG (TAB)
03/15/2026
03/21/2026
ORAL
625mg
BID
Possible GBS INFECTION
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: